- Report
- March 2022
- 165 Pages
Global
From €1798EUR$1,990USD£1,537GBP
- Report
- December 2022
- 170 Pages
Global
From €2259EUR$2,500USD£1,931GBP
- Report
- June 2024
- 150 Pages
Global
From €2259EUR$2,500USD£1,931GBP
- Report
- March 2024
- 151 Pages
Global
From €2259EUR$2,500USD£1,931GBP
- Report
- February 2023
- 119 Pages
Global
From €4066EUR$4,500USD£3,476GBP
- Report
- August 2022
- 115 Pages
Global
From €4066EUR$4,500USD£3,476GBP
- Report
- April 2023
- 111 Pages
Global
From €4292EUR$4,750USD£3,669GBP
- Report
- May 2025
- 85 Pages
Egypt
From €2688EUR$2,975USD£2,298GBP
€3162EUR$3,500USD£2,704GBP
- Report
- May 2025
- 85 Pages
Turkey
From €2688EUR$2,975USD£2,298GBP
€3162EUR$3,500USD£2,704GBP
- Report
- December 2024
- 83 Pages
Saudi Arabia
From €2688EUR$2,975USD£2,298GBP
€3162EUR$3,500USD£2,704GBP
- Report
- December 2024
- 87 Pages
Spain
From €2688EUR$2,975USD£2,298GBP
€3162EUR$3,500USD£2,704GBP
From €2688EUR$2,975USD£2,298GBP
€3162EUR$3,500USD£2,704GBP
- Report
- October 2024
- 82 Pages
India
From €2688EUR$2,975USD£2,298GBP
€3162EUR$3,500USD£2,704GBP
- Report
- August 2024
- 82 Pages
Japan
From €2688EUR$2,975USD£2,298GBP
€3162EUR$3,500USD£2,704GBP
- Report
- August 2024
- 80 Pages
Saudi Arabia
From €2688EUR$2,975USD£2,298GBP
€3162EUR$3,500USD£2,704GBP
- Report
- July 2024
- 80 Pages
Japan
From €2688EUR$2,975USD£2,298GBP
€3162EUR$3,500USD£2,704GBP
- Report
- June 2024
- 85 Pages
India
From €2688EUR$2,975USD£2,298GBP
€3162EUR$3,500USD£2,704GBP
- Report
- May 2024
- 182 Pages
Global
From €3456EUR$3,825USD£2,955GBP
€4066EUR$4,500USD£3,476GBP
- Report
- April 2024
- 187 Pages
Global
From €3456EUR$3,825USD£2,955GBP
€4066EUR$4,500USD£3,476GBP
- Report
- April 2024
- 180 Pages
Global
From €3456EUR$3,825USD£2,955GBP
€4066EUR$4,500USD£3,476GBP

Glaucoma is a group of eye diseases that damage the optic nerve, leading to vision loss. It is the leading cause of irreversible blindness worldwide. The glaucoma market within the optical industry is focused on providing treatments and technologies to diagnose and manage the disease. This includes medications, laser treatments, and surgical procedures. Additionally, the market includes devices such as tonometers, optical coherence tomography (OCT) systems, and visual field analyzers. These devices are used to measure intraocular pressure, detect structural changes in the eye, and assess the extent of vision loss.
Companies in the glaucoma market include Allergan, Bausch + Lomb, Carl Zeiss Meditec, Ellex, Glaukos, Hoya, Nidek, Topcon, and Ziemer Ophthalmic Systems. Show Less Read more